Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 198 | 3 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 52973 |
| 2395 | 2 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB | 4457 |
| 29828 | 1 | REGORAFENIB//FRUQUINTINIB//N DESETHYL SUNITINIB | 196 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | REGORAFENIB | authKW | 1559216 | 20% | 24% | 40 |
| 2 | FRUQUINTINIB | authKW | 804002 | 3% | 100% | 5 |
| 3 | N DESETHYL SUNITINIB | authKW | 643202 | 2% | 100% | 4 |
| 4 | HMPL 013 | authKW | 321601 | 1% | 100% | 2 |
| 5 | MULTIKINASE INHIBITOR | authKW | 292348 | 5% | 18% | 10 |
| 6 | GH H MONDOR | address | 214399 | 1% | 67% | 2 |
| 7 | O DESMETHYL GEFITINIB | authKW | 214399 | 1% | 67% | 2 |
| 8 | ADVERSE EVENT PROPHYLAXIS | authKW | 160800 | 1% | 100% | 1 |
| 9 | BIOANAL METAB PHAMACOKINET | address | 160800 | 1% | 100% | 1 |
| 10 | CH COCHIN HOTEL DIEU BROCA | address | 160800 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Chemistry, Analytical | 1759 | 41% | 0% | 80 |
| 2 | Biochemical Research Methods | 1751 | 32% | 0% | 62 |
| 3 | Pharmacology & Pharmacy | 703 | 36% | 0% | 70 |
| 4 | Oncology | 467 | 27% | 0% | 52 |
| 5 | Medical Laboratory Technology | 80 | 4% | 0% | 7 |
| 6 | Toxicology | 24 | 4% | 0% | 8 |
| 7 | Biochemistry & Molecular Biology | 2 | 8% | 0% | 15 |
| 8 | Chemistry, Medicinal | 1 | 2% | 0% | 3 |
| 9 | Radiology, Nuclear Medicine & Medical Imaging | 1 | 2% | 0% | 4 |
| 10 | Geriatrics & Gerontology | 0 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GH H MONDOR | 214399 | 1% | 67% | 2 |
| 2 | BIOANAL METAB PHAMACOKINET | 160800 | 1% | 100% | 1 |
| 3 | CH COCHIN HOTEL DIEU BROCA | 160800 | 1% | 100% | 1 |
| 4 | INFECT DIS SMIT | 160800 | 1% | 100% | 1 |
| 5 | KORNBERG GRP | 160800 | 1% | 100% | 1 |
| 6 | MEDCLIN PHARMACOL ANALYT CORE | 160800 | 1% | 100% | 1 |
| 7 | PFEP PLATEFORME EVALUAT PRECLIN | 160800 | 1% | 100% | 1 |
| 8 | RED TEMAT INVEST COOPERATIVA CANC | 160800 | 1% | 100% | 1 |
| 9 | SIMMONCOOPER CANC | 160800 | 1% | 100% | 1 |
| 10 | SINTESE ESTRUT ATIVIDADE | 160800 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | LATIN AMERICAN JOURNAL OF PHARMACY | 15555 | 8% | 1% | 16 |
| 2 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 10992 | 15% | 0% | 29 |
| 3 | BIOMEDICAL CHROMATOGRAPHY | 6280 | 6% | 0% | 12 |
| 4 | TARGETED ONCOLOGY | 3210 | 2% | 1% | 3 |
| 5 | BIOANALYSIS | 1754 | 2% | 0% | 4 |
| 6 | ACTA POLONIAE PHARMACEUTICA | 1691 | 2% | 0% | 4 |
| 7 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 1420 | 5% | 0% | 10 |
| 8 | CANCER MANAGEMENT AND RESEARCH | 1264 | 1% | 1% | 1 |
| 9 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 797 | 1% | 0% | 2 |
| 10 | THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 646 | 1% | 0% | 1 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | REGORAFENIB | 1559216 | 20% | 24% | 40 | Search REGORAFENIB | Search REGORAFENIB |
| 2 | FRUQUINTINIB | 804002 | 3% | 100% | 5 | Search FRUQUINTINIB | Search FRUQUINTINIB |
| 3 | N DESETHYL SUNITINIB | 643202 | 2% | 100% | 4 | Search N+DESETHYL+SUNITINIB | Search N+DESETHYL+SUNITINIB |
| 4 | HMPL 013 | 321601 | 1% | 100% | 2 | Search HMPL+013 | Search HMPL+013 |
| 5 | MULTIKINASE INHIBITOR | 292348 | 5% | 18% | 10 | Search MULTIKINASE+INHIBITOR | Search MULTIKINASE+INHIBITOR |
| 6 | O DESMETHYL GEFITINIB | 214399 | 1% | 67% | 2 | Search O+DESMETHYL+GEFITINIB | Search O+DESMETHYL+GEFITINIB |
| 7 | ADVERSE EVENT PROPHYLAXIS | 160800 | 1% | 100% | 1 | Search ADVERSE+EVENT+PROPHYLAXIS | Search ADVERSE+EVENT+PROPHYLAXIS |
| 8 | CHROMATOGRAPHY METHOD VALIDATION | 160800 | 1% | 100% | 1 | Search CHROMATOGRAPHY+METHOD+VALIDATION | Search CHROMATOGRAPHY+METHOD+VALIDATION |
| 9 | CORRECT TRIAL | 160800 | 1% | 100% | 1 | Search CORRECT+TRIAL | Search CORRECT+TRIAL |
| 10 | DFMQ 19 | 160800 | 1% | 100% | 1 | Search DFMQ+19 | Search DFMQ+19 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |